BMP ‐9 regulates the osteoblastic differentiation and calcification of vascular smooth muscle cells through an ALK 1 mediated pathway
The process of vascular calcification shares many similarities with that of physiological skeletal mineralization, and involves the deposition of hydroxyapatite crystals in arteries. However, the cellular mechanisms responsible have yet to be fully explained. Bone morphogenetic protein ( BMP ‐9) has...
Gespeichert in:
Veröffentlicht in: | Journal of cellular and molecular medicine 2015-01, Vol.19 (1), p.165-174 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The process of vascular calcification shares many similarities with that of physiological skeletal mineralization, and involves the deposition of hydroxyapatite crystals in arteries. However, the cellular mechanisms responsible have yet to be fully explained. Bone morphogenetic protein (
BMP
‐9) has been shown to exert direct effects on both bone development and vascular function. In the present study, we have investigated the role of
BMP
‐9 in vascular smooth muscle cell (
VSMC
) calcification. Vessel calcification in chronic kidney disease (
CKD
) begins pre‐dialysis, with factors specific to the dialysis milieu triggering accelerated calcification. Intriguingly,
BMP
‐9 was markedly elevated in serum from
CKD
children on dialysis. Furthermore,
in vitro
studies revealed that
BMP
‐9 treatment causes a significant increase in
VSMC
calcium content, alkaline phosphatase (
ALP
) activity and m
RNA
expression of osteogenic markers.
BMP
‐9‐induced calcium deposition was significantly reduced following treatment with the
ALP
inhibitor 2,5‐Dimethoxy‐
N
‐(quinolin‐3‐yl) benzenesulfonamide confirming the mediatory role of
ALP
in this process. The inhibition of
ALK
1 signalling using a soluble chimeric protein significantly reduced calcium deposition and
ALP
activity, confirming that
BMP
‐9 is a physiological
ALK
1 ligand. Signal transduction studies revealed that
BMP
‐9 induced Smad2, Smad3 and Smad1/5/8 phosphorylation. As these Smad proteins directly bind to Smad4 to activate target genes, si
RNA
studies were subsequently undertaken to examine the functional role of Smad4 in
VSMC
calcification. Smad4‐si
RNA
transfection induced a significant reduction in
ALP
activity and calcium deposition. These novel data demonstrate that
BMP
‐9 induces
VSMC
osteogenic differentiation and calcification
via
ALK
1, Smad and
ALP
dependent mechanisms. This may identify new potential therapeutic strategies for clinical intervention. |
---|---|
ISSN: | 1582-1838 1582-4934 |
DOI: | 10.1111/jcmm.12373 |